G-Pen Compared to Glucagen Hypokit for Severe Hypoglycemia Rescue in Adults With Type 1 Diabetes

Clinical trial NCT03738865 · COMPLETED

Trial details

NCT number: NCT03738865
Sponsor: Xeris Pharmaceuticals
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Insulin Hypoglycemia Type 1 Diabetes Mellitus Severe Hypoglycemia

Start date: 2018-09-27
Primary completion: 2019-03-29
Enrollment: 132

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.